Please check back for updates on speakers, agenda, and registration information.

SDDS 2025: Stanford Drug Discovery Symposium

Welcome to the 2025 Stanford Drug Discovery Symposium. This event has become a cornerstone in the drug discovery community for networking and collaboration. SDDS 2025 offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate two days of exciting talks and discussions, including the return of our poster session. We look forward to welcoming you to Stanford for SDDS 2025.

— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
 

New Venue!

We are excited to announce a new venue for SDDS 2025, located at the Frances C. Arrillaga Alumni Center at Stanford. This new space offers an enhanced attendee experience, with more room for networking, an expanded poster session, and convenient parking. We look forward to a dynamic environment for collaboration and innovation. 

Lifetime Achievement Awardees

Jens Juul Holst, MD, DMSc

Professor, Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen

Joel Habener, MD

Professor of Medicine, Harvard Medical School

Lotte Bjerre Knudsen, DMSc

Chief Scientific Advisor, Novo Nordisk

Participants

Srini Akkaraju, MD, PhD

Founder & Managing Partner, Samsara BioCapital.

Robert Bradway, MBA

Chairman and CEO, Amgen

Patrizia Cavazzoni, MD

Former Director, Center for Drug Evaluation and Resarch Food and Drug Administration

Levi Garraway, MD, PhD

Executive Vice President, Head of Global Product Dev, and CMO, Roche / Genentech

Alexander Hardy, MBA

President and CEO, BioMarin

Karin Immergluck, PhD

Associate Vice Provost, Office of Technology Licensing, Stanford

Christoph Lengauer, MD, PhD

Co-Founder and CSO, Curie.Bio

Mark McClellan, MD, PhD

Director and Robert J. Margolis, MD, Professor of Business, Medicine, and Policy, Margolis Institute for Health Policy, Duke University

Andrew Plump, MD, PhD

President of Research and Development, Takeda

Randy Schekman, PhD

Nobel Laureate, 2013; Professor of Molecular and Cell Biology, University of California, Berkeley

Caroline Stout

Partner, EcoRI Capital

 

Jonathan Thomas, PhD, JD

President and CEO, CIRM

Carolyn Bertozzi, PhD

Nobel Laureate 2022
Baker Family Director of Stanford ChEM-H

Robert Blum, MBA

President and CEO,
Cytokinetics

Navin Chaddha, MS

Managing Partner, Mayfield

Jane Grogan, PhD

Executive Vice President and Head of Research, Biogen

Stephen Hoge, MD

President,
Moderna

Karen Knudsen, MBA, PhD

CEO, American Cancer Society & American Cancer Society Cancer Action Network

Ashley Magargee, MBA

CEO, Genentech

Lloyd Minor, MD

Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine

Stephen Quake, D.Phil

Head of Science, Chan Zuckerberg Initiative

Marcus Schindler, PhD

Executive Vice President, Research & Early Development, and CSO, Novo Nordisk

Thomas Südhof, MD

Nobel Laureate 2013; Avram Goldstein Professor and Prof of Neurosurgery, Stanford University

Anne Wojcicki

CEO and Co-Founder, 23andMe

Jay Bradner, MD

Executive Vice President, R&D, and CSO, Amgen

Rob Califf, MD

Former Commissioner, U.S. Food and Drug Administration

Jennifer Doudna, PhD

Nobel Laureate 2020; Li Ka Shing Chancellor’s Chair, Professor, UC Berkley

Aida Habtezion, MD

Chief Medical Officer and Head of Worldwide Medical and Security, Pfizer

Thomas Hudson, MD

Versant Ventures

Samarth Kulkarni, PhD

CEO and Chairman of the Board, CRISPR Therapeutics

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, Food and Drug Administration

Becky Pferdehirt, PhD

Investing Partner, Andreessen Horowitz

John Reed, MD, PhD

Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson

Dan Sheeran, MBA

General Manager, Healthcare and Life Science, Amazon Web Services

Marc Tessier-Lavigne, PhD

CEO, Xaira Therapeutics

George Yancopoulos, MD, PhD

President and Chief Scientific Officer, Regeneron

Tentative Agenda

Please check back often as changes are anticipated. All times listed are PT.

Event Program & Poster

TBD

FAQs

Foundation Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Media Partners

Organizers

Amanda Chase, PhD

Associate Director of Strategic Research Development
Stanford Cardiovascular Institute

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Sanjay Malhotra, PhD

Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU

Joseph Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine
Stanford University School of Medicine
 

Francesca Mae G. Tongco, MS-HCA

Project Coordinator
Stanford Cardiovascular Institute


For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.